THE SPC BLOG

RSS

A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life

thumbnail

Hold the Front Page: Royalty involved in SPC decision!

thumbnail

Paris Court of Appeal overturns preliminary injunctions against Mylan and Sandoz/ MSD's ezetimibe/simvastatine SPCs

thumbnail

The AG's opinion in Santen

thumbnail

Opinion of Advocate General out on joined referrals C-650/17 (Royalty Pharma) and C-114/18 (Sandoz v Searle)

thumbnail

The SPC Blog Seminar 2019 is open for registration!

thumbnail

Update on the SPC export and stockpiling waiver

thumbnail

New SPC reference to the CJEU on Article 3(c) – Novartis (C-354/19)

thumbnail

Free SPC Seminar in London tomorrow!

thumbnail

C-443/17 - Abraxis CJEU Judgement

thumbnail

Forum Institut SPC Seminar 2019

thumbnail

Darunavir in Swedish Preliminary Injunction Proceedings

thumbnail

Update on SPCs in China

thumbnail

No more launch at risk in France?

thumbnail

Recent developments to the SPC manufacturing waiver proposal

thumbnail

Call for comments for C-673/18 (Santen v INPI)

For more from “THE SPC BLOG” please visit thespcblog.blogspot.com